SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-21-062737
Filing Date
2021-05-07
Accepted
2021-05-07 07:02:03
Documents
3
Period of Report
2021-05-07
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2113800d3_8k.htm 8-K 18089
2 EXHIBIT 99.1 tm2113800d3_ex99-1.htm EX-99.1 31616
3 GRAPHIC tm2113800d3_ex99-1img01.jpg GRAPHIC 7257
  Complete submission text file 0001104659-21-062737.txt   60964
Mailing Address 2488 DUNWIN DRIVE MISSISSAUGA A6 L5L 1J9
Business Address 2488 DUNWIN DRIVE MISSISSAUGA A6 L5L 1J9 (416) 595-0627
Trillium Therapeutics Inc. (Filer) CIK: 0001616212 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36596 | Film No.: 21900189
SIC: 2834 Pharmaceutical Preparations